股票/基金 实时行情 股吧

简称:太龙药业 代码:600222


会计年度:2019-06-30收入分布
项目名称主营业务收入主营业务成本主营业务毛利毛利率
分部间抵销-31,629,870.15-31,944,804.64314,934.49-1.00
合计593,122,061.88379,675,767.41213,446,294.4735.99
其他438,943.68403,523.5735,420.118.07
药品研发服务96,515,912.2453,957,548.3342,558,363.9144.09
药品药材流通45,271,843.5542,328,450.212,943,393.346.50
药品制造482,525,232.56314,931,049.94167,594,182.6234.73

会计年度:2018-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计1,194,794,347.49792,643,920.40402,150,427.0933.66
其他(补充)3,319,728.262,337,056.11982,672.1529.60
药品研发服务188,399,406.6995,646,306.1592,753,100.5449.23
药品药材流通194,802,887.85175,456,269.1819,346,618.679.93
医药制造808,272,324.69519,204,288.96289,068,035.7335.76

会计年度:2018-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计583,145,473.34400,083,377.09183,062,096.2531.39
其他(补充)519,151.14525,322.09-6,170.95-1.19
药品研发服务72,091,615.6334,059,677.5738,031,938.0652.76
医药流通129,653,739.64115,889,820.5013,763,919.1410.62
医药制造380,880,966.93249,608,556.93131,272,410.0034.47

会计年度:2017-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计1,166,180,438.78811,854,846.41354,325,592.3730.38
药品流通311,484,635.00261,642,033.5949,842,601.4116.00
药品研发服务123,898,283.2941,774,892.4682,123,390.8366.28
药品制造730,797,520.49508,437,920.36222,359,600.1330.43

会计年度:2017-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
分部间抵销3,514.463,499.4315.030.43
技术研发4,482.121,436.563,045.5667.95
医药流通13,212.9010,763.182,449.7218.54
医药制造35,000.2825,911.689,088.6025.97

    2/9 转到